LeukO 2026 to Unite the Global Leukemia Community This September
The LeukO 2026 virtual congress is scheduled for September 2026 to address global challenges in leukemia research and patient care. The event will feature international experts discussing clinical strategies, molecular characterization, and healthcare policy.
Why it matters
As leukemia remains a significant global health burden, international collaboration is essential for improving patient outcomes and addressing disparities in care.
LeukO 2026: Global Virtual Congress on Leukemias will take place on September 3–4, 2026 , bringing together international leaders in hematology, leukemia research, transplantation, cellular therapy, supportive care, and patient advocacy for two days of scientific exchange.
Held virtually as part of the OncoDaily O Series, the congress will cover more than 40 scientific topics, spanning leukemia diagnosis and molecular characterization, contemporary treatment strategies, emerging therapies, transplantation, survivorship, global access, and healthcare policy.
The program is designed around both the rapidly changing science of leukemia and the practical challenges clinicians face when translating advances into care.
Leukemias remain an important part of the global cancer burden. Although survival has improved substantially over recent decades, outcomes continue to vary according to leukemia subtype, patient age, disease biology, access to specialized treatment, and regional healthcare resources.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in